Cleared Traditional

K092117 - SCENAR

K092117 is an FDA 510(k) clearance for SCENAR, manufactured by Ritm Okb Zao. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 318-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2010
Decision
318d
Days
Class 2
Risk

K092117 is an FDA 510(k) clearance for the SCENAR, MODEL 10. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Ritm Okb Zao (Taganrog, RU). The FDA issued a Cleared decision on May 28, 2010 after a review of 318 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ritm Okb Zao devices

FDA 510(k) Submission Details - K092117

510(k) Number K092117 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 2009
Decision Date May 28, 2010
Days to Decision 318 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
170d slower than avg
Panel avg: 148d · This submission: 318d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 167
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K092117.
NEUROTECH PLUS
K112258 · Bio-Medical Research, Ltd. · Jan 2012
KNEEHAB XP
K110350 · Bio-Medical Research, Ltd. · Aug 2011
4 CHANNELS MULTIPLE MODEL DIGITAL ELECTRICAL STIMULATOR, MODEL NUVOSTIM IV, WL-2504A
K100399 · Well-Life Healthcare Limited · Jun 2010
HIVOX ELECTRIC STIMULATOR TENS & EMS, HD2
K092448 · Hivox Biotek, Inc. · Mar 2010
LUMBOFIX CONDUCTIVE GARMENT, MODEL 420 BACK
K091317 · Bio-Medical Research, Ltd. · Jun 2009
EMPI ACTIVE TRANSCUTANEOUS NERVE STIMULATOR
K090922 · Empi · Jun 2009